SCI & TECH● LOW1h ago · Oct 25, 2026, 8:06 PM
Xencor reports promising kidney cancer drug results, plans late-stage trial
Seeking Alpha Tech · global
Xencor has reported promising results for a kidney cancer drug and plans to proceed with a late-stage trial. This development could represent a significant step forward in kidney cancer treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH40m agoMusk warns of AI lending crunch after SpaceX closes $40B GPU financingSeeking Alpha TechSCI & TECH1h agoCBD COP17: Nigeria, six others each win $50,000 grant for biodiversity projectsPremium TimesSCI & TECH1h agoAI has a language gap. That could be a problem for some voters.PoliticoSCI & TECH2h agoPM to inaugurate bovine research centre on Oct 30timesofindia.indiatimes.com · India